Mesoblast Limited (OTCMKTS:MEOBF) Short Interest Up 25.1% in November

Mesoblast Limited (OTCMKTS:MEOBF) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 13,699,800 shares, a growth of 25.1% from the November 15th total of 10,952,000 shares. Based on an average trading volume of 65,200 shares, the short-interest ratio is currently 210.1 days.

Mesoblast Stock Performance

Mesoblast stock remained flat at $1.03 during midday trading on Monday. 4,156,982 shares of the company were exchanged, compared to its average volume of 74,003. The firm has a 50 day simple moving average of $1.06 and a two-hundred day simple moving average of $0.84. Mesoblast has a twelve month low of $0.10 and a twelve month high of $1.41.

About Mesoblast

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.